A Phase 2 Evaluation of a Novel Co-Formulation of Pramlintide and Regular Insulin to Improve Postprandial Glycemic Control in Adults with Type 1 Diabetes (T1D)

Category Primary study
JournalJournal of the Endocrine Society
Year 2021
This article has no abstract
Epistemonikos ID: 3ec0e8dcd0ac03fbb31ccf1a8e0c090bcdb4aae2
First added on: Dec 07, 2023